---
category: news
title: "Kiromic Announces Submission of Two IND Applications for PD1 Gamma-delta CAR - T cell Therapy with the FDA"
excerpt: "Kiromic BioPharma (\"the Company\") (NASDAQ:KRBP), a target discovery and gene-editing company utilizing artificial intelligence and its proprietary neural network platform with"
publishedDateTime: 2020-12-17T17:45:00Z
originalUrl: "https://www.benzinga.com/pressreleases/20/12/b18840129/kiromic-announces-submission-of-two-ind-applications-for-pd1-gamma-delta-car-t-cell-therapy-with-t"
webUrl: "https://www.benzinga.com/pressreleases/20/12/b18840129/kiromic-announces-submission-of-two-ind-applications-for-pd1-gamma-delta-car-t-cell-therapy-with-t"
ampWebUrl: "https://amp.benzinga.com/amp/content/18840129"
cdnAmpWebUrl: "https://amp-benzinga-com.cdn.ampproject.org/c/s/amp.benzinga.com/amp/content/18840129"
type: article

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

secured: "635ez7hZ+5UfdObernJb/EcIb9vJl7F/hilNI0WSp5FIOckklu5591Yj9zonhZlczYZCcLn+AiOUMnXAFxg4/QqB5QM40FsaYyMYoje45IX69y7YYSvKAW5/6/G7kkzs9rqgTnrIhje6ivB7KNuRQR3Pz0iv30pQ45Gz4cxO+okP/gb1KZ3O23hctz8CA1Lk101j07oY+9/pRFRdXjJLQkVV9S7ea3EvRuczQoiqk+tUxNNEO1hYzHNuf4dGYeWpRENeloRqhImIYr9xkC//B90jkZ/Z6vO1xx4wDqaNiP3NPvZGoK0gHOrE0YDfFCL1mkrjoQ3Itjo/hTM0N6mQWV/FWqeCUip83iFHGHmpuew=;S0mR1adbDhn2oiqDbFBmsw=="
---

